| 7 | 1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA
12/2012
-
12/2006 |
| 5 | Caffeine (No Doz)FDA LinkGeneric
12/2010
-
04/2005 |
| 5 | Peptides (Polypeptides)IBA
12/2010
-
02/2007 |
| 5 | Amyloid beta-PeptidesIBA
09/2010
-
02/2007 |
| 4 | Purinergic P1 Receptors (Adenosine Receptor)IBA
03/2009
-
09/2004 |
| 3 | Pharmaceutical PreparationsIBA
12/2010
-
06/2005 |
| 3 | Purinergic P1 Receptor AntagonistsIBA
03/2009
-
04/2005 |
| 3 | Hypnotics and Sedatives (Sedatives)IBA
10/2006
-
09/2004 |
| 3 | Ethanol (Ethyl Alcohol)IBA
10/2006
-
09/2004 |
| 2 | Atorvastatin (Lipitor)FDA Link
11/2021
-
12/2010 |
| 2 | Neuroprotective AgentsIBA
04/2012
-
01/2011 |
| 2 | Dopamine (Intropin)FDA LinkGeneric
08/2011
-
01/2010 |
| 2 | Pilocarpine (Ocusert)FDA LinkGeneric
04/2011
-
02/2006 |
| 2 | Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
05/2010
-
05/2007 |
| 2 | Cannabinoid Receptor AgonistsIBA
06/2007
-
11/2006 |
| 2 | Anti-Anxiety Agents (Anxiolytics)IBA
10/2005
-
09/2004 |
| 1 | Propolis (Bee Bread)IBA
01/2021 |
| 1 | pinocembrinIBA
01/2021 |
| 1 | AnkyrinsIBA
08/2013 |
| 1 | Irritants (Vesicants)IBA
08/2013 |
| 1 | Biomarkers (Surrogate Marker)IBA
07/2012 |
| 1 | LithiumIBA
04/2012 |
| 1 | Valproic Acid (Depakote)FDA LinkGeneric
04/2012 |
| 1 | Agrochemicals (Agricultural Chemicals)IBA
01/2012 |
| 1 | Heparin (Liquaemin)FDA LinkGeneric
08/2011 |
| 1 | MidkineIBA
08/2011 |
| 1 | Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
08/2011 |
| 1 | Therapeutic UsesIBA
07/2011 |
| 1 | CarrageenanIBA
07/2011 |
| 1 | Gastric Inhibitory Polypeptide (Glucose Dependent Insulinotropic Peptide)IBA
04/2011 |
| 1 | proanthocyanidinIBA
12/2010 |
| 1 | Glutamic Acid (Glutamate)FDA Link
12/2010 |
| 1 | Desipramine (Pertofrane)FDA LinkGeneric
09/2010 |
| 1 | Cyclooxygenase 2 (Cyclooxygenase-2)IBA
05/2010 |
| 1 | Proteins (Proteins, Gene)FDA Link
05/2010 |
| 1 | Phosphatidylinositols (Phosphatidylinositol)IBA
03/2010 |
| 1 | Scopolamine (Hyoscine)FDA Link
03/2010 |
| 1 | Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
03/2010 |
| 1 | 5- quinoxalin- 6- ylmethylenethiazolidine- 2,4- dioneIBA
03/2010 |
| 1 | amyloid beta-protein (1-40)IBA
03/2010 |
| 1 | istradefyllineIBA
01/2010 |
| 1 | Adenosine A2 Receptor AntagonistsIBA
01/2010 |
| 1 | Reserpine (Serpasil)FDA Link
08/2009 |
| 1 | Methylphenidate (Ritalin)FDA LinkGeneric
03/2009 |
| 1 | Reactive Oxygen Species (Oxygen Radicals)IBA
12/2008 |
| 1 | CannabinoidsIBA
06/2007 |
| 1 | (3R)- ((2,3- dihydro- 5- methyl- 3- ((4- morpholinyl)methyl)pyrrolo- (1,2,3- de)- 1,4- benzoxazin- 6- yl)(1- naphthalenyl))methanone (WIN 55,212)IBA
06/2007 |
| 1 | Glutathione (Reduced Glutathione)IBA
02/2007 |
| 1 | AntioxidantsIBA
02/2007 |
| 1 | Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA
02/2006 |
| 1 | Cholinergic Agents (Cholinergics)IBA
02/2006 |
| 1 | Adenosine (Adenocard)FDA LinkGeneric
10/2005 |
| 1 | Dopamine Receptors (Dopamine Receptor)IBA
10/2005 |
| 1 | Adenosine A2A Receptor (Adenosine A2A Receptors)IBA
04/2005 |
| 1 | ZM 241385 (ZM241385)IBA
04/2005 |
| 1 | Adenosine A1 ReceptorIBA
04/2005 |
| 1 | 1,3-dipropyl-8-cyclopentylxanthineIBA
04/2005 |
| 1 | Phenol (Carbolic Acid)FDA Link
04/2005 |